logo-loader

Does US court ruling spell the end for Indivior?

Published: 16:20 01 Sep 2017 BST

Proactive Investors editor Ian Lyall discusses the patent infringement case that effectively gives the green light to a company called Dr Reddy’s to produce a copycat version of Indivior PLC's (LON:INDV) heroin subsitute drug Suboxone at a fraction of the current price.

The immediate reaction on the markets was one of horror as 40%, or £1.1bn was wiped from Indivior’s value.

Oriole Resources outlines 2023 achievements and future exploration plans

Oriole Resources PLC (AIM:ORR) CEO Tim Livesey and chief financial officer Bob Smeeton join Proactive's Stephen Gunnion with details of the company's 2023 financial and operational performance. Livesey highlighted successful exploration programs in Cameroon, at the Bibemi and Mbe projects,...

2 hours, 38 minutes ago